Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS3650277 A
Tipo de publicaciónConcesión
Fecha de publicación21 Mar 1972
Fecha de presentación17 Feb 1970
Fecha de prioridad24 Feb 1969
También publicado comoDE2008316A1
Número de publicaciónUS 3650277 A, US 3650277A, US-A-3650277, US3650277 A, US3650277A
InventoresUlf Hakan Sjostrand, Per Ake Oberg
Cesionario originalLkb Medical Ab
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Apparatus for influencing the systemic blood pressure in a patient by carotid sinus nerve stimulation
US 3650277 A
Resumen
A system for reducing and controlling the blood pressure of a hypertensive patient has electrical pulse stimulation of the carotid-sinus nerves controlled by the arterial blood pressure of the patient in such a manner that the number of stimulation pulses within each heart cycle is determined by the arterial means blood pressure whereas the distribution of stimulation pulses over the heart cycle is a function of the arterial pulse wave shape with the pulse frequency being greater during the first portion of the heart cycle.
Imágenes(3)
Previous page
Next page
Reclamaciones  disponible en
Descripción  (El texto procesado por OCR puede contener errores)

United States Patent Sjostrand et al.

[ Mar. 21, 1972 APPARATUS FOR INFLUENCING THE SYSTEMIC BLOOD PRESSURE IN A PATIENT BY CAROTID SINUS NERVE STIMULATION Ulf Hakan Sjostrand, Uppsala', Per Alte Oberg, Brunna, both of Sweden LKB Medical AB, Bromma, Sweden Feb. 17, 1970 Inventors:

Assignee:

Filed:

Appl. No.:

Foreign Application Priority Data Feb. 4, 1969 Sweden ..2528/69 U.S. Cl. ..l28/419 C, 128/421 Int. Cl. ..A6ln l/36 Field of Search ..128/418,419 R, 421,422,423,

128/205 A, 2.05 P, 2.05 E, 2.05 M, 2.05 B, 2.05 R, 206 A, 2.06 R, 2.1 B, 2.1 R

blood pressure Arterial 8 Pressu're transducer 0 Q Mean value circuit Differeutiating circuit [56] References Cited UNITED STATES PATENTS 3,358,690 12/1967 Cohen 128/419 R 3,199,508 8/1965 Roth ....128/2.06 R 3,421,511 1/1969 Schwartz et al ..128l418 OTHER PUBLICATIONS Bilgutay et al., Transactions of American Society of Artificial lntemal Organs, Vol. X, 1964, pp. 387- 393 Primary Examiner-William E. Kamm Attorney-Zabel, Baker, York and Jones [57] ABSTRACT A system for reducing and controlling the blood pressure of a hypertensive patient has electrical pulse stimulation of the carotid-sinus nerves controlled by the arterial blood pressure of the patient in such a manner that the number of stimulation pulses within each heart cycle is determined by the arterial means blood pressure whereas the distribution of stimulation pulses over the heart cycle is a function of the arterial pulse wave shape with the pulse frequency being greater during the first portion of the heart cycle.

6 Claims, 6 Drawing Figures PATENTEDMARZI m2 3.650.277

SHEET 1 [IF 3 Fig.1 P

Arteriof Vusomotor blood 5 pressure umreceptors centers Effector systems Arterial blood- 8 Flg 2 pressure Left sinus nerve Right sinus nerve APPARATUS FOR INFLUENCING THE SYSTEMIC BLOOD PRESSURE IN A PATIENT BY CAROTID SINUS NERVE STIMULATION The present invention is related to an apparatus for influencing the systemic blood pressure in human beings and more particularly for reducing and controlling the blood pressure in hypertensive patients.

The blood pressure regulatory system of higher mammals and man is preferably described and studied as a closed-loop control system. FIG. 1 in the enclosed drawing illustrates a lay-out of this control system. The arterial systemic blood pressure is sensed by baroreceptors 2 in the body, which can be regarded as pressure-signal-transducers to convey information on the actual arterial blood pressure through afferent nerve paths to the vasomotor center 3. Man has several such baroreceptor areas, the most important ones being located at the aorta arch and in the two carotid-sinus regions. As components in a closed-loop control system these baroreceptors may be regarded as parameter sensors conveying information to the vasomotor center of the actual arterial blood pressure. With reference to a closed-loop control system, the vasomotor center can be regarded as a comparator and regulator which compares the information about the actual blood pressure received from the baroreceptors with information about the desired blood pressure received from other cardio-vascular centers and other receptors in the body and which in response to this comparison influences those effector systems 4 in the body directly determining the systemic arterial blood pressure. These effectors are primarily the heart, the volume rate of which is an important factor determining the systemic blood pressure, and the peripheral-vascular system, in particular the arterial system but also the venous system, the contraction and dilation of which affect the blood pressure. For the treatment of hypertensive patients one uses at the present in most cases various types of drugs which either affect the effectors, primarily the peripheral-vascular system for reduction of the blood volume, or have an inhibiting effect upon the nerve activity from the vasomotor center to the effectors. These drugs have, however, the very serious disadvantage that they impair considerably the capacity of the natural biological blood pressure regulatory system for producing the natural and desired adjustment of the blood pressure to the activity of the patient and other factors, which would normally cause changes in the blood pressure.

Therefore one has in the last years become interested in the possibility of influencing the blood pressure through the nerve activity on the afferent nerve paths from the baroreceptors to the vasomotor center by artificial stimulation of these nerves by means of electric pulses so that the natural nerve activity is supplemented or replaced with an artificially increased nerve activity, in response to which the vasomotor center is caused to reduce the blood pressure. In this way it is possible to obtain a reduced pressure level while maintaining the biological blood pressure regulatory system unaffected so that this can provide a natural control of the blood pressure at the reduced level. This method should of course be particularly advantageous in those cases where the hypertension is caused by an abnormally low sensitivity of the baroreceptors so that for a given arterial blood pressure the baroreceptors produce a substantially lower nerve activity than would be the case in a normotensive patient. Nerves suitable for such an electrical stimulation are primarily the sinus nerves from the baroreceptors in the two carotid-sinus areas, as these nerves are comparatively easily accessible. Experiments carried out with electrical stimulation of the sinus nerves or the carotid-sinus areas with electric pulse series have also verified that such a stimulation has a certain reducing effect on the blood pressure. However, the practical results obtained have been comparatively limited, which seems primarily to have been due to the fact that the artificial electrical stimulation has not been sufficiently similar to the natural nerve activity from the baroreceptors, wherefore the vasomotor center has not responded to the artificially stimulated nerve activity in the intended manner.

The object of the present invention is therefore to provide an improved apparatus for influencing the blood pressure in a patient, in particular for reducing the blood pressure of a hypertensive patient, by electrical stimulation of afferent nerve paths from the baroreceptors of the patient, in particular the sinus nerves from the carotid-sinus areas. The device according to the invention comprises as already suggested in the prior art an electrode or stimulator assembly which can be applied on or close to an afferent nerve for stimulation thereof with short electric pulses and a pulse generator connected to said stimulator assembly for supplying stimulating pulses thereto. Preferably one uses two electrode or stimulator assemblies to be applied to each one of the sinus nerves of the patients in which case the pulse generator is provided with two pulse outputs connected to said two stimulator assemblies respectively. The device according to the invention is characterized in that it comprises a signal generator for producing a control signal for the pulse generator dependent on the. heart activity of the patient and that the pulse generator produces in response to said control signal during each heart cycle a pulse series of limited length, which starts at the beginning of the heart cycle and in which the majority of pulses appear during the first portion of the heart cycle.

The device according to the invention satisfies two essential conditions for a true-to-nature stimulation of the afferent nerve activity on the sinus nerves, namely on the one hand that the stimulation is synchronized to the heart activity of the patient and consists of a limited pulse series during each heart cycle and on the other hand that this pulse series has the majority of its pulses concentrated to the first portion of the heart cycle.

in a more refined embodiment of the invention, the signal generator responsive to the heart activity of the patient may consist of a pressure transducer which is connected to an artery of the patient and produces an electric output signal substantially representing the instantaneous arterial blood pressure of the patient. Such a pressure transducer may for instance consist of a strain gauge device coupled to the artery through a catheter inserted therein. It is also possible to mount the pressure transducer externally on the artery so as to be affected by the stresses in the wall of the vessel, which stresses are dependent on the blood pressure in the vessel. It is of course also possible to use other types of pressure sensitive electrical transducers, as for instance piezoelectric crystals. The electric output signal which is obtained from the pressure transducer and which varies with the instantaneous arterial blood pressure of the patient is supplied to signal transforming circuits which produce a first signal representative of the arterial mean blood pressure of the patient and a second signal representative of the derivative or rate of change of the arterial blood pressure of the patient and which sum said first and second signals and produces a signal corresponding to said sum, said last-mentioned signal being connected to the pulse generator as a control signal therefor and the pulse generator being adapted to produce pulses having a pulse frequency corresponding to the amplitude of the control signal supplied to the generator. Thus, also in this embodiment of the invention a stimulation is obtained which is synchronized with the heart activity of the patient in that a limited pulse series is produced during each arterial pulse cycle so as to start at the beginning of the pulse cycle. However, each such pulse series will contain a number of pulses determined by the prevailing arterial means blood pressure and display a pulse frequency modulation determined by the shape of the arterial pulse wave during the current pulse cycle. As the arterial pulse wave has a large positive derivative of comparatively short duration at the beginning of the pulse cycle and thereafter during the remaining, substantially longer portion of the pulse cycle a smaller negative derivative, each pulse series will display a pulse frequency which after an initial and rapid increase in pulse frequency decreases continuously from its maximum value at the beginning of the pulse series. With such a design of the device according to the invention the artificially stimulated nerve activity will duplicate the natural biological nerve activity from the baroreceptors with a much higher fidelity. As, furthermore, the artificial stimulation of the nerve activity is dependent on the mean blood pressure of the patient as well as the derivative of the blood pressure, that is the shape of the arterial pulse wave, the device according to the invention will form an integral part of the natural biological blood pressure regulator system. Related to this regulator system the device. according to the invention can be regarded as a parameter sensor which supplements the natural biological parameter sensors in the blood pressure regulatory system formed by the baroreceptors of the patient.

In the following the invention will be further described with reference to the accompanying drawing, in which HO. 1 is the schematic and very simplified block diagram described in the foregoing for the natural biological blood pressure regulator system;

FIG. 2 shows by way of example the block diagram for an embodiment of a device according to the invention, in which the artificial stimulation of the nerve activity is dependent on the arterial mean blood pressure as well as the derivative of the arterial blood pressure;

FIG. 3 is a diagram schematically illustrating the natural afferent nerve activity from a baroreceptor during an arterial pulse cycle for different arterial mean blood pressures;

FIG. 4 is a diagram of the mean pulse frequency of the stimulating pulses as a function of the mean pressure for the device according to the invention illustrated in FIG. 2;

H6. 5 is a diagram illustrating schematically the pulse series produced by the device according to the invention illustrated in FIG. 2 for a sinusoidally varying pressure and for different settings of the device; and

FIG. 6 shows a number of blood pressure curves illustrating the blood pressure regulation obtained in experiments on dogs with a device according to FIG. 2 as compared with the blood pressure regulation caused by the natural baroreceptors in the carotid-sinus areas.

In FIG. 3 curve A illustrates schematically the shape of the normal arterial pulse wave during an arterial pulse cycle, whereas curve B illustrates the corresponding ECG-signal. The diagrams C, D, E, F and G respectively illustrate the nature of the afferent nerve activity on the sinus nerve during the heart pulse cycle for different arterial mean blood pressures. As illustrated by these diagrams this nerve activity consists of pulse series. A characteristic property of this nerve activity is that it is synchronized with the arterial pulse cycle so that the nerve activity consists of a pulse series for each arterial pulse cycle starting at the beginning of the arterial pulse cycle and having its pulses primarily concentrated in the first portion of the arterial pulse cycle. The number of pulses in each pulse series, that is the mean pulse frequency of the pulse series, is dependent on the arterial mean blood pressure in such a manner that the number of pulses increases with increasing arterial mean blood pressure. There is a lower threshold level at about 40-50 mm. Hg. below which no nerve activity exists and an upper saturation level at about 200-250 mm. Hg. above which the nerve activity is saturated and each pulse series comprises a maximum number of pulses which is not additionally increased for increasing arterial means blood pressure. Another characteristic property of the afferent pressure responsive nerve activity is that each pulse series is modulated with respect to its pulse frequency, generally speaking in such a manner that the pulse frequency decreases continuously during the duration of the pulse series from a maximum frequency at the beginning of the pulse series.

In a device according to the invention for electrical stimulation of the afferent nerve activity for instance on the sinus nerve, in order to influence the blood pressure the aim must consequently be to compose this stimulation in such a manner that it copies or resembles as closely as possible the natural nerve activity illustrated in FIG. 3 and described above.

For this purpose the device according to the invention may in the most simple case comprise a pulse generator having a pulse output connected to a stimulator or electrode assembly applied on or close to a selected nerve or nerves and designed to produce in response to a starting signal a pulse series having a predetermined number of pulses and a predetermined pulse frequency. For the synchronization of the pulse generator and thus the nerve stimulation with the heart cycle of the patient one may preferably use an electrode located at or close to the heart of the patient for picking up an ECG-signal which is supplied to the pulse generator as a control signal therefor, in which case the pulse generator is designed to start a pulse series in response to the readily detectable R-wave in the ECG- signal at the beginning of each a heart cycle. By adjustment of the length, the pulse frequency and possibly also the'pulse frequency modulation of the pulse series produced by the pulse generator to the natural biological regulatory response of the patient in question it is possible to achieve a desired reduction of the blood pressure level of the patient. However, it is appreciated that in such a simple device according to the invention the artificial stimulation of the nerve activity will not adapt itself automatically to the prevailing arterial mean blood pressure of the patient as the natural nerve activity does (F IG. 3) and neither will it be affected by any variations in the shape of the arterial pulse wave. Although such a simple device has produced good results in experiments that have been made, it is more advantageous to make also the artificial stimulation on the nerve activity dependent of the arterial mean blood pressure on the patient and also of the shape of the arterial pulse wave.

FIG. 2 illustrates the fundamental block diagram for such a more sophisticated device according to the invention. This device includes two identical electrode or stimulator assemblies 5 and 6 adapted to be applied on or close to the sinus nerves of the patient for electrical stimulation of the nerve activity therein. Each such stimulator or electrode assembly may for instance include two loop-shaped electrodes arranged to enclose the nerve at spaced positions. Also other types and locations of the stimulator assemblies may of course be used. The two stimulator assemblies 5 and 6 are connected to separate pulse outputs from a controlled pulse generator 7 of any suitable design, which on its two outputs produces pulses having a pulse frequency determined by a control signal, as for instance a direct voltage signal, applied to the control input of the pulse generator. Consequently the two stimulators 5 and 6 are supplied with identical pulse series from the pulse generator 7. However, the one output of the pulse generator is provided with a delay circuit 15 so that the pulse series on this output is delayed relative to the pulse series on the other output by a delay time which is shorter than the shortest interval between two successive pulses in the pulse series. In this way cross-stimulation between the two stimulators 5 and 6, that is between the left side and the right side of the patient, is prevented. The device includes also a pressure transducer 8 of suitable type, which can be connected or applied to an artery of the patient and which produces an electric output signal which is substantially proportional to the instantaneous arterial blood pressure of the patient. As mentioned in the foregoing, such a pressure sensitive signal transducer may consist of a strain gauge transducer which is connected to the artery through a catheter inserted into the artery or is mounted externally on the artery so as to be affected by the mechanical stresses in the wall of the artery.

The output signal from the pressure transducer 8, representing the instantaneous arterial blood pressure, is through an amplifier 9 supplied to two signal transforming circuits l0 and 11. The circuit 10 is designed to calculate on the basis of the input signal the arterial mean blood pressure and to produce an output signal proportional thereto. The calculation of the arterial mean blood pressure may be carried out in various manners. For instance the circuit 10 may consists of a mean value rectifying circuit having a suitable time constant. In a practical device according to the invention, however, the circuit 10 includes two peak detecting amplifiers which are connected to the signal from the pressure transducer 8 with opposite polarities so that the one amplifier produces an output signal representing the systolic blood pressure, whereas the other amplifier produces an output signal representing the diastolic blood pressure. These two output signals are supplied to an analog summing circuit which sums the two signals according to the equation menn dlnalollc fi auatollc dlaslollc) This is an approximative expression for the arterial mean blood pressure P based upon a substitution of a triangular curve for the arterial pulse wave. The output signal from the circuit 10, proportional to the calculated arterial mean blood pressure, is connected through a variable circuit element 12, as for instance a potentiometer, to the one input ofa signal adding amplifier 13. By means ofahe potentiometer 12 it is possible to vary the proportionality factor for the signal representing the mean blood pressure.

The second signal transforming circuit 11 is a differentiating circuit which produces an output signal having an amplitude proportional to the derivative or rate of change of the arterial blood pressure and a polarity corresponding to the sign of this derivative. The output signal from the differentiating circuit 1] is supplied through a variable circuit element 14, for instance a potentiometer, to the second input of the signal adding amplifier 13. By means of the potentiometer 14 it is consequently possible to vary the proportionality factor for the signal from the differentiating circuit 11 representating the derivative of the blood pressure. The signal adding amplifier I3 sums the two input signals and produces an output signal proportional to the sum. This output signal is connected to the pulse generator 7 as a control signal therefor. Consequently the pulse generator will generate pulses having a frequency proportional to the sum of the prevailing arterial mean blood pressure, as calculated by the circuit 10, and the instantaneous derivative of the arterial blood pressure, as determined by the circuit 11. However, the pulse generator 7 is designed to have a lower threshold level for the input signal below which threshold value no pulses are generated. This lower threshold level for the input signal corresponds preferably to a constant non-varying blood pressure of about 40-50 mm. Hg. Further the pulse generator has preferably an upper saturation frequency of for instance about 300 Hz., which is reached for an input signal corresponding to a constant non-varying blood pressure of for instance about 250-300 mm. Hg. It is appreciated that the pulse series generated by the pulse generator 7 will have a mean pulse frequency determined by the magnitude of the calculated arterial mean blood pressure and the setting of the potentiometer l2 and a pulse frequency modulation determined by the derivative of the arterial blood pressure, that is the shape of the arterial pulse wave, and the setting of the potentiometer 14.

FIG. 4 is a diagram illustrating the relationship between the mean pulse frequency of the pulse series produced by the pulse generator 7 and the mean pressure sensed by the pressure transducer 8 for a pressure which varies sinusoidally about the mean pressure with the frequency 2 Hz. This relationship is substantially linear and substantially independent of the setting of the potentiometer 14, that is of the magnitude of the component of the control signal for the pulse generator 7 corresponding to the derivative of the pressure. This is also what one would expect, as for a signal varying periodically about a constant value, the time integral of the positive derivative of the signal is always equal to the time integral of the negative derivative of the signal.

In FIG. 5 the diagrams H, J and K illustrate the pulse series produced by the pulse generator 7 for different settings of the potentiometer 14, when the pressure transducer 8 is affected by a pressure which varies sinusoidally about a given mean pressure with the frequency 2 Hz. as illustrated by the curve L. The pulse series illustrated by the diagram H is obtained when the potentiometer 14 has such a setting that the signal supplied to the signal adding amplifier 13 from the differentiating circuit 11 is zero, that is when the pulse generator 7 is controlled only by the signal representing the mean pressure from the circuit 10. As expected one obtains in this case a constant pulse frequency, the magnitude of which is determined by the mean pressure. The diagrams J and K respectively illustrate pulse series obtained when the potentiometer 14 has such a setting that a certain signal proportional to the derivative of the pressure is supplied from the circuit 11 to the adder amplifier 13, this derivative representing signal component being larger in the case illustrated by the curve K than in the case illustrated by the diagram J. As can be seen these two pulse series contain substantially the same number of pulses during each period of the varying pressure (curve L), whereas the pulses are distributed differentially over the period dependent on the relative magnitude of the derivative representing signal component from the circuit 11.

Experiments have been carried out on animals in order to compare on the one hand the blood pressure reducing and regulating effects that can be obtained by artificial stimulation of the nerve activity in the sinus nerves by means of a device according to the invention designed as illustrated in FIG. 2 as against the natural blood pressure regulating effect caused by the natural afferent nerve activity on the sinus nerves in response to the baroreceptors in the carotid-sinus areas. For these experiments dogs have been used, as the vascular system in dogs is very similar to that in man and as anesthetic techniques are developed for dogs which do not give cause to any disturbance in the blood pressure regularoty system.

The experiments were carried out in the following manner: The two carotid-sinus regions of the animal were dissected free. The common carotid artery on each side was provided with a device by means of which the artery could be clamped for a desired time interval and thereafter reopened. On each side of a catheter was inserted into the carotid-sinus and fixed by a ligature as close as possible to the bifurcation between the external and the internal carotid arteries. These two catheters were connected through polyethene catheters and a valve to a catheter inserted into the femoral vein. By means of the valve it was possible to open or close the communication between the two sinuses and the femoral vein. By clamping the two common carotid arteries and simultaneously opening the c0mmunication between the two sinuses and the femoral vein it was possible to produce such a low and pulsation-free blood pressure in the sinuses that the normal nerve activity from the baroreceptors in the two carotid-sinus areas was completely interrupted. Consequently, this corresponded to a complete disconnection of the natural baroreceptors from the natural biological blood pressure regulatory system of the experimental animal.

The sinus nerves from the carotid-sinus areas were also dissected free and on these nerves the two stimulators 5 and 6 of the device according to the invention (FIG. 2) were applied near to the origin of the nerves in the sinuses. The pressure transducer 8 of the device according to the invention (FIG. 2) was connected to a catheter inserted in the femoral artery. The output signal from the pressure transducer 8 was connected not only to the two signal transforming circuits l0 and 11 in the device according to the invention but also to a recorder for recording the arterial blood pressure of the animal during the experiment.

At the experiments the two common carotid arteries were clamped at the same time as the two sinuses were connected to the femoral vein through the catheters inserted in the sinuses and the valve device. This caused a pronounced rise in the arterial blood pressure of the experimental animal, which was exactly what could be expected, as the normal nerve activity from the baroreceptors in the two carotid-sinus areas was interrupted, as explained in the foregoing. This state was maintained until it was certain that a stable arterial blood pressure (at the higher level) had been obtained. Thereafter the two common carotid arteries were reopened instantaneously and at the same time the communication between the catheters inserted in the sinuses and the femoral vein respectively was interrupted. In this way a very rapid transient rise in the intrasinusal blood pressure was produced and thus a stepfunction activation of the baroreceptors in the carotid-sinus areas. The arterial blood pressure of the experimental animal returned then to its original value under the influence of the reappearing normal afferent nerve activity in the sinus nerves from the baroreceptors. This natural regulatory response of the natural biological blood pressure regulatory system under the influence of the operation of the natural baroreceptors was studied by means of the recording of the arterial blood pressure of the animal made by the recorder. The curve M in FIG. 6 illustrates the typical variation of the systolic pressure of an experimental animal during such an experimenL The experiments showed that the variations in the systolic pressure and the diastolic pressure respectively were so similar that it was only necessary to record one of them. In the experiment corresponding to curve M in FIG. 6 the common carotid arteries were clamped at the time T and reopened at the time T As can be seen, a well damped regulatory response is obtained on the momentary stepwise rise in the intrasinusal pressure and the systemic blood pressure is returned comparatively rapidly to a constant value equal to the value before the experiment, which shows also that the natural biological blood pressure regulatory system has not been permanently affected by the experiment.

The experiment described above was thereafter repeated but with the difference that at the time T the common carotid arteries were not opened and neither was the communication between the catheters inserted in the sinuses and the femoral vein respectively interrupted. Consequently the natural baroreceptors in the two carotid-sinus areas remain inoperative. Instead at the time T an artificial stimulation of the sinus nerves was started by means of the device according to the invention (FIG. 2). The curves N, O and P in FIG. 6 illustrate typical regulatory responses in the systolic pressure of the experimental animal under the influence of such an electric stimulation of the sinus nerves for different settings of the potentiometer 14 in the device (FIG. 2), that is for different magnitudes of the control signal component of the pulse generator dependent on the derivative of the blood pressure. At the experiment illustrated by curve N the potentiometer 14 had such a setting that no signal component from the circuit 1] dependent on the derivative of the blood pressure was sup plied to the adder amplifier l3 and thus to the pulse generator 7. Consequently, in this case the stimulation was carried out with a constant pulse frequency during the entire cardial cycle, the magnitude of this pulse frequency being determined by the arterial mean blood pressure of the animal. As can be seen this artificial stimulation of the sinus nerves caused the blood pressure to return to a level substantially equal to the value before the clamping of the carotid arteries. However, the blood pressure returned to its original value through very pronounced oscillations, remaining for a considerable time, and the regulatory response has consequently in this case a very low damping.

In the experiment illustrated by curve the potentiometer 14 had such a setting that a certain but comparatively small signal component representing the derivative of the blood pressure was supplied to the pulse generator 7. In this case a considerably more damped response was obtained, but still the amplitude and the duration of the oscillations were considerably larger than in the natural biological regulatory response illustrated by curve M.

In the experiment illustrated by curve P the potentiometer 14 had such a setting that a substantially larger signal component representative of the derivative of the blood pressure was supplied to the pulse generator than in the experiment illustrated by curve 0. As can be seen, in this case a well damped regulatory response was obtained which was very similar to the natural biological regulatory response illustrated by curve M.

Consequently, the experiments show that it is essential that the artificial stimulation of the afferent nerve activity has a pulse frequency which is modulated in such a way, preferably in dependence of the derivative of the arterial blood pressure,

that the majority of the stimulation pulses appear during the first portion of the hear cycle, if a regulatory response is to be achieved which is similar to the natural regulatory response caused by the natural nerve activity from the baroreceptors.

Between the different experiments which artificial stimulation of the nerve activity with a device according to the invention the natural regulatory response was checked repeatedly in that the clamping of the carotid arteries was removed as described above in connection with curve M in FIG. 6. The purpose of this was to check that the artificial stimulation of the sinus nerves did not have any permanently remaining effect upon the natural blood pressure regulatory system. No such remaining changes could be found.

As it is known that the biological baroreceptors have different sensitivities for the positive and the negative derivative of the blood pressure respectively, experiments have also been made with a device according to the invention as shown in FIG. 2, in which, however, the differentiating circuit 11 was so designed that it could be set to have unequally large amplifications for the positive derivative and the negative derivative respectively. Comparative experiments were made on the one hand with unequally large amplifications for the positive and the negative derivatives and on the other hand with equally large amplification for both derivatives. The regulatory responses obtained at these experiments did not, however, shown any marked fundamental differences. Just as described in the foregoing, however, it was observed that a large signal component dependent on the derivative of the blood pressure supplied to the pulse generator 7 produces a more damped response than a small signal component dependent on the derivative. Further experiments have shown that a relatively large signal component, dependent on the mean blood pressure from the circuit 10 (set by means of the potentiometer 12) to the pulse generator 7, i.e., a higher mean pulse frequency for the stimulation, gives a lower blood pressure level than a smaller static signal component from the circuit 10 to the pulse generator 7, i.e., a lower mean pulse frequency for the stimulation.

It is appreciated that in the practical use of a device according to the invention it may be necessary to adjust the relative magnitude of the mean pulse frequency of the stimulation, which is dependent on the arterial mean blood pressure of the patient, and the pulse frequency modulation which is dependent on the blood pressure derivative of the patient as well as to adjust the lower threshold level for the pulse generation and the maximum saturation pulse frequencyrespectively to the patient concerned if optimum results are to be obtained.

In the experiments on dogs the stimulation was made with square wave pulses having an amplitude of 2 v. and a pulse length of 0.1 msec. However, it is appreciated that the pulse amplitude as well as the pulse length must be adjusted to the actual design of the stimulator assemblies and their location relative to the nerves to be stimulated so that the desired nerve activity is achieved in the nerves. However, it seems that a pulse amplitude within the range l-5 v. and a pulse length within the range 0.1-2 msec. should be suitable.

In a device according to the invention the two stimulator assemblies and the pressure transducer sensing the arterial blood pressure may be permanently implanted in the body and connected through wire conductors to a unit located outside the said external unit including the pulse generator, the signal transforming circuits and the necessary power source. Alternatively the stimulator assemblies and the pressure transducer may be coupled inductively to said external unit. It is also possible to miniaturize the device so that the complete device can be subcutaneously implanted, in which case it is preferably provided with inductively rechargeable batteries so that the device does not have to be removed for replacement of the batteries.

What is claimed is:

l. A system for influencing the natural biological blood pressure regulatory system in an individual, in particular for reducing and controlling the blood pressure in a hypertensive individual, by electrical pulse stimulation of an afferent nerve from a baroreceptor in the individual, said system comprising:

1. pressure sensitive transducer means adapted to be connected to the arterial system of the individual for sensing the arterial blood pressure and producing an electric output signal substantially representing the instantaneous arterial blood pressure in the individual;

. signal transforming means receiving the transducer output signal and including (a) a first signal transforming circuit providing an output signal substantially proportional to the mean value of the transducer output signal, and (b) a second signal transforming circuit providing an output signal whose amplitude is proportional to the derivative of the transducer output signal and whose polarity corresponds to the algebraic sign of said derivative;

3. signal combining means for additively combining the output signals of said first and second signal transforming circuits and providing an output signal whose amplitude is a function of said combined signals;

4. a frequency controlled pulse generator receiving the output signal of said signal combining means as a frequency control signal for generating output pulses having a frequency proportional to the amplitude of the output signal of said signal combining means; and

. stimulator means connecting to receive the output pulses of said pulse generator and including at least one electrode means adapted for connection to an afferent nerve from a baroreceptor in the individual.

2. A system according to claim 1, wherein said pulse generator has a minimum threshold signal value for its frequency control signal to initiate operation of the generator.

3. A system according to claim 1, comprising variable signal attenuating means connected between the outputs of said first and second signal transforming circuits and the input of said signal combining means for variation of the relative magnitudes of the signals combined by said signal combining means.

4. A system according to claim 1, wherein said second signal transforming circuit has unequally large proportionality factors for the positive and negative derivatives respectively of the transducer output signal.

5. A system according to claim 1, wherein said pulse generator has a pulse frequency range up to about 300 Hz.

6. A system for influencing the natural biological blood pressure regulatory system in an individual, in particular for reducing and controlling the blood pressure in a hypertensive individual, by electric pulse stimulation of an afferent nerve from a baroreceptor in the individual, said system comprising:

1. pressure responsive transducer means adapted to be connected to the arterial system in the individual for sensing the arterial blood pressure and producing an output signal substantially representing the instantaneous arterial blood pressure in the individual;

2. signal transforming means responsive to the transducer output signal and including (a) a first signal transforming circuit providing an output signal substantially proportional to the mean value of the transducer output signal, and (b) a second signal transforming circuit providing an output signal whose amplitude is substantially proportional to the derivative of the transducer output signal and whose polarity corresponds to the algebraic sign of said derivative;

3. signal combining means for additively combining the output signals of said first and second signal transforming circuits to provide an output signal whose amplitude is a function of said combined signals;

4. a frequency controlled pulse generator connected to receive the output signal of said signal combining means as a frequency control signal to generate output pulses having a pulse frequency proportional to the amplitude of the output signal of said signal combining means; said pulse enerator having two out uts for said output pulses; 5. stimu ator means including rig t and left electrode means connected to receive the output pulses from the two outputs respectively of the pulse generator and adapted for connection to the right and left carotid-sinus nerves respectively in the individual; and 6. a pulse delay circuit in the one generator output connection for providing a time delay shorter than the shortest interval between two successive output pulses from the generator to prevent cross-stimulation between the right and left carotid-sinus nerves in the individual.

* IIK

Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US3199508 *25 Abr 196210 Ago 1965W R Medical Electronies CoCoding of physiological signals
US3358690 *18 Nov 196419 Dic 1967Cohen Marvin MHeart stimulator utilizing a pressuresensitive semiconductor
US3421511 *10 Dic 196514 Ene 1969Medtronic IncImplantable electrode for nerve stimulation
Otras citas
Referencia
1 *Bilgutay et al., Transactions of American Society of Artificial Internal Organs, Vol. X, 1964, pp. 387 393
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US4165750 *9 Mar 197828 Ago 1979Aleev Leonid SBioelectrically controlled electric stimulator of human muscles
US4201219 *3 Mar 19786 May 1980Bozal Gonzalez Jose LCardiac pace-maker
US4243024 *2 Abr 19796 Ene 1981The United States Of America As Represented By The Secretary Of The NavyG-Protection system sensing a change in acceleration and tilt angle
US4289140 *31 Ago 197915 Sep 1981Carpenter David ASignal processing system
US4338945 *2 Mar 197913 Jul 1982Clinical Engineering Laboratory LimitedMethod and randomized electrical stimulation system for pain relief
US4453547 *6 Abr 198112 Jun 1984Physio Technology, Inc.T-Wave inhibiting system
US4509521 *31 Ene 19839 Abr 1985Barry Terrence JHeadache relief method
US4566456 *18 Oct 198428 Ene 1986Cordis CorporationApparatus and method for adjusting heart/pacer rate relative to right ventricular systolic pressure to obtain a required cardiac output
US4600017 *19 Jul 198415 Jul 1986Cordis CorporationPacing lead with sensor
US4702254 *30 Dic 198527 Oct 1987Jacob ZabaraNeurocybernetic prosthesis
US4763646 *9 Dic 198716 Ago 1988Siemens AktiengesellschaftHeart pacemaker
US4770177 *18 Feb 198613 Sep 1988Telectronics N.V.Apparatus and method for adjusting heart/pacer relative to changes in venous diameter during exercise to obtain a required cardiac output.
US4791931 *13 Ago 198720 Dic 1988Pacesetter Infusion, Ltd.Demand pacemaker using an artificial baroreceptor reflex
US4860751 *4 Feb 198529 Ago 1989Cordis CorporationActivity sensor for pacemaker control
US4867164 *26 Oct 198719 Sep 1989Jacob ZabaraNeurocybernetic prosthesis
US5025807 *25 Ene 198925 Jun 1991Jacob ZabaraNeurocybernetic prosthesis
US5083563 *16 Feb 199028 Ene 1992Telectronics Pacing Systems, Inc.Implantable automatic and haemodynamically responsive cardioverting/defibrillating pacemaker
US5199428 *22 Mar 19916 Abr 1993Medtronic, Inc.Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload
US5458626 *27 Dic 199317 Oct 1995Krause; Horst E.Method of electrical nerve stimulation for acceleration of tissue healing
US5540734 *28 Sep 199430 Jul 1996Zabara; JacobCranial nerve stimulation treatments using neurocybernetic prosthesis
US5575809 *11 Jun 199319 Nov 1996Kabushiki Kaisya AdvanceElectrical stimulator
US5578061 *3 Oct 199526 Nov 1996Pacesetter AbMethod and apparatus for cardiac therapy by stimulation of a physiological representative of the parasympathetic nervous system
US5690681 *29 Mar 199625 Nov 1997Purdue Research FoundationMethod and apparatus using vagal stimulation for control of ventricular rate during atrial fibrillation
US5700282 *13 Oct 199523 Dic 1997Zabara; JacobHeart rhythm stabilization using a neurocybernetic prosthesis
US5707400 *19 Sep 199513 Ene 1998Cyberonics, Inc.Treating refractory hypertension by nerve stimulation
US5727558 *14 Feb 199617 Mar 1998Hakki; A-HamidNoninvasive blood pressure monitor and control device
US5916239 *24 Nov 199729 Jun 1999Purdue Research FoundationMethod and apparatus using vagal stimulation for control of ventricular rate during atrial fibrillation
US6050952 *14 Ene 199818 Abr 2000Hakki; A-HamidMethod for noninvasive monitoring and control of blood pressure
US6058331 *27 Abr 19982 May 2000Medtronic, Inc.Apparatus and method for treating peripheral vascular disease and organ ischemia by electrical stimulation with closed loop feedback control
US6073048 *17 Nov 19956 Jun 2000Medtronic, Inc.Baroreflex modulation with carotid sinus nerve stimulation for the treatment of heart failure
US652292627 Sep 200018 Feb 2003Cvrx, Inc.Devices and methods for cardiovascular reflex control
US685080126 Sep 20011 Feb 2005Cvrx, Inc.Mapping methods for cardiovascular reflex control devices
US698577426 Sep 200110 Ene 2006Cvrx, Inc.Stimulus regimens for cardiovascular reflex control
US701034526 Oct 20017 Mar 2006Medtronic, Inc.Method and apparatus to minimize effects of a cardiac insult
US705085611 Ene 200223 May 2006Medtronic, Inc.Variation of neural-stimulation parameters
US715528416 Ene 200326 Dic 2006Advanced Bionics CorporationTreatment of hypertension
US715883226 Sep 20012 Ene 2007Cvrx, Inc.Electrode designs and methods of use for cardiovascular reflex control devices
US71943138 Jun 200420 Mar 2007Cardiac Pacemakers, Inc.Baroreflex therapy for disordered breathing
US721896426 Oct 200115 May 2007Medtronic, Inc.Closed-loop neuromodulation for prevention and treatment of cardiac conditions
US739511919 May 20051 Jul 2008Cvrx, Inc.Implantable electrode assembly having reverse electrode configuration
US746090624 Dic 20032 Dic 2008Cardiac Pacemakers, Inc.Baroreflex stimulation to treat acute myocardial infarction
US74851042 Jun 20033 Feb 2009Cvrx, Inc.Systems and methods for controlling renovascular perfusion
US7486991 *24 Dic 20033 Feb 2009Cardiac Pacemakers, Inc.Baroreflex modulation to gradually decrease blood pressure
US749974227 Mar 20033 Mar 2009Cvrx, Inc.Electrode structures and methods for their use in cardiovascular reflex control
US7502650 *21 Sep 200410 Mar 2009Cvrx, Inc.Baroreceptor activation for epilepsy control
US7509166 *24 Dic 200324 Mar 2009Cardiac Pacemakers, Inc.Automatic baroreflex modulation responsive to adverse event
US75428005 Abr 20052 Jun 2009Cardiac Pacemakers, Inc.Method and apparatus for synchronizing neural stimulation to cardiac cycles
US75553415 Abr 200530 Jun 2009Cardiac Pacemakers, Inc.System to treat AV-conducted ventricular tachyarrhythmia
US75964138 Jun 200429 Sep 2009Cardiac Pacemakers, Inc.Coordinated therapy for disordered breathing including baroreflex modulation
US761699727 Mar 200310 Nov 2009Kieval Robert SDevices and methods for cardiovascular reflex control via coupled electrodes
US761700514 Ago 200610 Nov 2009Ardian, Inc.Methods and apparatus for thermally-induced renal neuromodulation
US762045127 Feb 200617 Nov 2009Ardian, Inc.Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US76239265 Abr 200424 Nov 2009Cvrx, Inc.Stimulus regimens for cardiovascular reflex control
US764711413 Sep 200412 Ene 2010Cardiac Pacemakers, Inc.Baroreflex modulation based on monitored cardiovascular parameter
US765343813 May 200526 Ene 2010Ardian, Inc.Methods and apparatus for renal neuromodulation
US76573123 Nov 20032 Feb 2010Cardiac Pacemakers, Inc.Multi-site ventricular pacing therapy with parasympathetic stimulation
US766859419 Ago 200523 Feb 2010Cardiac Pacemakers, Inc.Method and apparatus for delivering chronic and post-ischemia cardiac therapies
US770688424 Dic 200327 Abr 2010Cardiac Pacemakers, Inc.Baroreflex stimulation synchronized to circadian rhythm
US771794816 Ago 200718 May 2010Ardian, Inc.Methods and apparatus for thermally-induced renal neuromodulation
US773434810 May 20058 Jun 2010Cardiac Pacemakers, Inc.System with left/right pulmonary artery electrodes
US77473238 Jun 200429 Jun 2010Cardiac Pacemakers, Inc.Adaptive baroreflex stimulation therapy for disordered breathing
US77565834 Nov 200513 Jul 2010Ardian, Inc.Methods and apparatus for intravascularly-induced neuromodulation
US776500010 May 200527 Jul 2010Cardiac Pacemakers, Inc.Neural stimulation system with pulmonary artery lead
US7765008 *31 Oct 200727 Jul 2010Metacure LimitedMethod of controlling blood pressure
US77694413 Nov 20053 Ago 2010The Board Of Regents Of The University Of OklahomaCardiac neuromodulation and methods of using same
US77833539 Nov 200624 Ago 2010Cardiac Pacemakers, Inc.Automatic neural stimulation modulation based on activity and circadian rhythm
US778794617 Sep 200431 Ago 2010Cardiac Pacemakers, Inc.Patient monitoring, diagnosis, and/or therapy systems and methods
US780161423 Oct 200621 Sep 2010Cvrx, Inc.Stimulus regimens for cardiovascular reflex control
US78138127 Jul 200612 Oct 2010Cvrx, Inc.Baroreflex stimulator with integrated pressure sensor
US7840271 *20 Jul 200523 Nov 2010Cvrx, Inc.Stimulus regimens for cardiovascular reflex control
US785333312 Jun 200614 Dic 2010Ardian, Inc.Methods and apparatus for multi-vessel renal neuromodulation
US786056323 Nov 200528 Dic 2010The Board Of Regents Of The University Of OklahomaCardiac neuromodulation and methods of using same
US786988124 Dic 200311 Ene 2011Cardiac Pacemakers, Inc.Baroreflex stimulator with integrated pressure sensor
US787341324 Jul 200618 Ene 2011Cardiac Pacemakers, Inc.Closed loop neural stimulation synchronized to cardiac cycles
US787341828 Abr 200618 Ene 2011Medtronic, Inc.Variation of neural stimulation parameters
US792535227 Mar 200912 Abr 2011Synecor LlcSystem and method for transvascularly stimulating contents of the carotid sheath
US793714318 Oct 20053 May 2011Ardian, Inc.Methods and apparatus for inducing controlled renal neuromodulation
US794940010 Nov 200924 May 2011Cvrx, Inc.Devices and methods for cardiovascular reflex control via coupled electrodes
US7962216 *16 Abr 200814 Jun 2011National Cerebral And Cardiovascular CenterCardiac pacing system, blood pressure regulating system, and cardiac disease treatment system by substituting native biological regulatory function
US796607131 Oct 200721 Jun 2011Metacure LimitedMethod and apparatus for regulating glucose level
US800079323 May 200816 Ago 2011Cardiac Pacemakers, Inc.Automatic baroreflex modulation based on cardiac activity
US800255318 Ago 200323 Ago 2011Cardiac Pacemakers, Inc.Sleep quality data collection and evaluation
US8002718 *30 Jun 200623 Ago 2011Siemens AktiengesellschaftShockwave system control dependent on patient's blood pressure
US800553930 Ene 200923 Ago 2011Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US801019518 Feb 201130 Ago 2011National Cerebral And Cardiovascular CenterCardiac pacing system by substituting native biological regulatory function
US801019923 Feb 201130 Ago 2011National Cerebral And Cardiovascular CenterBlood pressure regulating system by substituting native biological regulatory function
US802405024 Dic 200320 Sep 2011Cardiac Pacemakers, Inc.Lead for stimulating the baroreceptors in the pulmonary artery
US8060206 *7 Jul 200615 Nov 2011Cvrx, Inc.Baroreflex modulation to gradually decrease blood pressure
US8086314 *29 Oct 200227 Dic 2011Cvrx, Inc.Devices and methods for cardiovascular reflex control
US810987910 Ene 20067 Feb 2012Cardiac Pacemakers, Inc.Assessing autonomic activity using baroreflex analysis
US81168832 Feb 200714 Feb 2012Synecor LlcIntravascular device for neuromodulation
US812169323 Oct 200821 Feb 2012Cardiac Pacemakers, Inc.Baroreflex stimulation to treat acute myocardial infarction
US812656024 Dic 200328 Feb 2012Cardiac Pacemakers, Inc.Stimulation lead for stimulating the baroreceptors in the pulmonary artery
US813137113 Abr 20066 Mar 2012Ardian, Inc.Methods and apparatus for monopolar renal neuromodulation
US813137219 Mar 20076 Mar 2012Ardian, Inc.Renal nerve stimulation method for treatment of patients
US813137330 Mar 20106 Mar 2012Cardiac Pacemakers, Inc.Baroreflex stimulation synchronized to circadian rhythm
US814015510 Mar 200920 Mar 2012Cardiac Pacemakers, Inc.Intermittent pacing therapy delivery statistics
US814531625 Jul 200527 Mar 2012Ardian, Inc.Methods and apparatus for renal neuromodulation
US81453176 Mar 200627 Mar 2012Ardian, Inc.Methods for renal neuromodulation
US81505183 Jun 20053 Abr 2012Ardian, Inc.Renal nerve stimulation method and apparatus for treatment of patients
US81505196 Mar 20063 Abr 2012Ardian, Inc.Methods and apparatus for bilateral renal neuromodulation
US81505206 Mar 20063 Abr 2012Ardian, Inc.Methods for catheter-based renal denervation
US817570512 Oct 20048 May 2012Cardiac Pacemakers, Inc.System and method for sustained baroreflex stimulation
US81757116 Mar 20068 May 2012Ardian, Inc.Methods for treating a condition or disease associated with cardio-renal function
US819025728 May 200929 May 2012Cardiac Pacemakers, Inc.System to treat AV-conducted ventricular tachyarrhythmia
US821920117 Abr 200710 Jul 2012Metacure LimitedSmooth muscle controller for controlling the level of a chemical in the blood stream
US82244373 Oct 200817 Jul 2012Cvrx, Inc.Baroreflex activation for sedation and sleep
US82497056 Mar 200821 Ago 2012Cvrx, Inc.Devices, systems, and methods for improving left ventricular structure and function using baroreflex activation therapy
US824970830 Ene 200921 Ago 2012Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US826041230 Ene 20094 Sep 2012Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US828538921 Jul 20109 Oct 2012Cardiac Pacemakers, Inc.Automatic neural stimulation modulation based on motion and physiological activity
US8290595 *7 Jul 200616 Oct 2012Cvrx, Inc.Method and apparatus for stimulation of baroreceptors in pulmonary artery
US830661518 Ene 20106 Nov 2012Cardiac Pacemakers, Inc.Method and apparatus for delivering chronic and post-ischemia cardiac therapies
US831571330 Abr 200920 Nov 2012Medtronic, Inc.Techniques for placing medical leads for electrical stimulation of nerve tissue
US832102327 Ene 200927 Nov 2012Cardiac Pacemakers, Inc.Baroreflex modulation to gradually decrease blood pressure
US834789114 Nov 20068 Ene 2013Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US835578928 Abr 200615 Ene 2013Medtronic, Inc.Method and apparatus providing asynchronous neural stimulation
US83699547 Mar 20115 Feb 2013Synecor LlcSystem and method for transvascularly stimulating contents of the carotid sheath
US839655615 Dic 201012 Mar 2013Cardiac Pacemakers, Inc.Transcutaneous neurostimulator for treating hypertension
US840687615 Ene 201026 Mar 2013Cardiac Pacemakers, Inc.Closed loop neural stimulation synchronized to cardiac cycles
US8417334 *26 Oct 20019 Abr 2013Medtronic, Inc.Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions
US841735413 May 20109 Abr 2013Cardiac Pacemakers, Inc.Methods for using a pulmonary artery electrode
US843342313 Dic 201030 Abr 2013Ardian, Inc.Methods for multi-vessel renal neuromodulation
US844263817 May 201014 May 2013Cardiac Pacemakers, Inc.Adaptive baroreflex stimulation therapy for disordered breathing
US84426404 Ene 201014 May 2013Cardiac Pacemakers, Inc.Neural stimulation modulation based on monitored cardiovascular parameter
US844464014 Sep 201221 May 2013Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US845239430 Ene 200928 May 2013Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US845239820 May 200928 May 2013Cardiac Pacemakers, Inc.Method and apparatus for synchronizing neural stimulation to cardiac cycles
US845459411 Ago 20094 Jun 2013Medtronic Ardian Luxembourg S.A.R.L.Apparatus for performing a non-continuous circumferential treatment of a body lumen
US84577464 Ago 20114 Jun 2013Cardiac Pacemakers, Inc.Implantable systems and devices for providing cardiac defibrillation and apnea therapy
US847305730 Oct 200925 Jun 2013Medtronic, Inc.Shunt-current reduction housing for an implantable therapy system
US84730766 Sep 201125 Jun 2013Cardiac Pacemakers, Inc.Lead for stimulating the baroreceptors in the pulmonary artery
US847841430 Abr 20082 Jul 2013Cvrx, Inc.Baroreflex activation for pain control, sedation and sleep
US849869831 Ago 200930 Jul 2013Medtronic, Inc.Isolation of sensing and stimulation circuitry
US852704530 Oct 20093 Sep 2013Medtronic, Inc.Therapy system including cardiac rhythm therapy and neurostimulation capabilities
US85270643 Dic 20083 Sep 2013Cardiac Pacemakers, Inc.System for stimulating autonomic targets from pulmonary artery
US853277930 Ene 200910 Sep 2013Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US853279330 Abr 200910 Sep 2013Medtronic, Inc.Techniques for placing medical leads for electrical stimulation of nerve tissue
US853522213 Mar 200717 Sep 2013Cardiac Pacemakers, Inc.Sleep detection using an adjustable threshold
US85385355 Ago 201017 Sep 2013Rainbow Medical Ltd.Enhancing perfusion by contraction
US85485857 Dic 20101 Oct 2013Cardiac Pacemakers, Inc.Concurrent therapy detection in implantable medical devices
US854860014 Sep 20121 Oct 2013Medtronic Ardian Luxembourg S.A.R.L.Apparatuses for renal neuromodulation and associated systems and methods
US85510696 Mar 20068 Oct 2013Medtronic Adrian Luxembourg S.a.r.l.Methods and apparatus for treating contrast nephropathy
US856006031 Ago 200915 Oct 2013Medtronic, Inc.Isolation of sensing and stimulation circuitry
US85600765 Nov 201015 Oct 2013Cvrx, Inc.Devices and methods for electrode implantation
US857165526 Ene 201029 Oct 2013Cardiac Pacemakers, Inc.Multi-site ventricular pacing therapy with parasympathetic stimulation
US857168726 Ago 201029 Oct 2013Cardiac Pacemakers, Inc.Transcutaneous neurostimulator for modulating cardiovascular function
US85832368 Mar 201012 Nov 2013Cvrx, Inc.Devices and methods for cardiovascular reflex control
US859479417 Jul 200826 Nov 2013Cvrx, Inc.Baroreflex activation therapy with incrementally changing intensity
US860635617 Ago 200410 Dic 2013Cardiac Pacemakers, Inc.Autonomic arousal detection system and method
US860635913 Abr 200710 Dic 2013Cvrx, Inc.System and method for sustained baroreflex stimulation
US861199630 Ene 200917 Dic 2013Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US862042314 Mar 201131 Dic 2013Medtronic Ardian Luxembourg S.A.R.L.Methods for thermal modulation of nerves contributing to renal function
US862628215 Nov 20127 Ene 2014Cardiac Pacemakers, Inc.Baroreflex modulation to gradually change a physiological parameter
US862629016 Ago 20117 Ene 2014Enopace Biomedical Ltd.Acute myocardial infarction treatment by electrical stimulation of the thoracic aorta
US86262991 Dic 20107 Ene 2014Enopace Biomedical Ltd.Thoracic aorta and vagus nerve stimulation
US862630011 Mar 20117 Ene 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for thermally-induced renal neuromodulation
US86263013 Jun 20137 Ene 2014Cardiac Pacemakers, Inc.Automatic baroreflex modulation based on cardiac activity
US864986320 Dic 201011 Feb 2014Rainbow Medical Ltd.Pacemaker with no production
US865775615 Feb 201125 Feb 2014Cardiac Pacemakers, Inc.Implantable device employing movement sensing for detecting sleep-related disorders
US866064815 Nov 201225 Feb 2014Cardiac Pacemakers, Inc.Implantable and rechargeable neural stimulator
US866649518 Mar 20054 Mar 2014Metacure LimitedGastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US86849989 Mar 20121 Abr 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for inhibiting renal nerve activity
US868821030 Ene 20091 Abr 2014Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US868821126 Ago 20101 Abr 2014Cardiac Pacemakers, Inc.Percutaneous neurostimulator for modulating cardiovascular function
US869411913 May 20108 Abr 2014Samson Neurosciences Ltd.Endovascular electrostimulation near a carotid bifurcation in treating cerebrovascular conditions
US871252218 Oct 200529 Abr 2014Cvrx, Inc.System for setting programmable parameters for an implantable hypertension treatment device
US871253124 May 201229 Abr 2014Cvrx, Inc.Automatic baroreflex modulation responsive to adverse event
US871878919 Abr 20106 May 2014Cvrx, Inc.Electrode structures and methods for their use in cardiovascular reflex control
US872163712 Jul 201313 May 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for performing renal neuromodulation via catheter apparatuses having inflatable balloons
US872813712 Feb 201320 May 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for thermally-induced renal neuromodulation
US872813812 Feb 201320 May 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for thermally-induced renal neuromodulation
US874082522 Ago 20133 Jun 2014Sympara Medical, Inc.Methods and devices for treating hypertension
US874089612 Jul 20133 Jun 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for performing renal neuromodulation via catheter apparatuses having inflatable balloons
US874733822 Ago 201310 Jun 2014Sympara Medical, Inc.Methods and devices for treating hypertension
US875590721 May 201317 Jun 2014Cvrx, Inc.Devices and methods for electrode implantation
US87684696 Ago 20091 Jul 2014Enteromedics Inc.Systems for regulation of blood pressure and heart rate
US876847011 May 20101 Jul 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for monitoring renal neuromodulation
US877125220 May 20058 Jul 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and devices for renal nerve blocking
US877491314 Nov 20068 Jul 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for intravasculary-induced neuromodulation
US877491830 Ene 20098 Jul 2014Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US877492221 May 20138 Jul 2014Medtronic Ardian Luxembourg S.A.R.L.Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
US878446312 Feb 201322 Jul 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for thermally-induced renal neuromodulation
US879298520 Ene 200629 Jul 2014Metacure LimitedGastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US880549430 Jul 201312 Ago 2014Cardiac Pacemakers, Inc.System and method to deliver therapy in presence of another therapy
US880550125 Ene 201212 Ago 2014Cardiac Pacemakers, Inc.Baroreflex stimulation to treat acute myocardial infarction
US880550731 Oct 200712 Ago 2014Metacure LimitedMethods for controlling labor and treating menstrual cramps in uterine muscle
US880551323 Abr 201312 Ago 2014Cardiac Pacemakers, Inc.Neural stimulation modulation based on monitored cardiovascular parameter
US880554516 Abr 201312 Ago 2014Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for multi-vessel renal neuromodulation
US88121048 Sep 201019 Ago 2014Cardiac Pacemakers, Inc.Method and apparatus for automated control of pacing post-conditioning
US88185131 Mar 201226 Ago 2014Cardiac Pacemakers, Inc.Baroreflex stimulation synchronized to circadian rhythm
US88185142 Jul 201326 Ago 2014Medtronic Ardian Luxembourg S.A.R.L.Methods for intravascularly-induced neuromodulation
US883824627 Sep 200616 Sep 2014Cvrx, Inc.Devices and methods for cardiovascular reflex treatments
US88456295 Abr 201030 Sep 2014Medtronic Ardian Luxembourg S.A.R.L.Ultrasound apparatuses for thermally-induced renal neuromodulation
US885216328 Jun 20137 Oct 2014Medtronic Ardian Luxembourg S.A.R.L.Renal neuromodulation via drugs and neuromodulatory agents and associated systems and methods
US885578310 Nov 20117 Oct 2014Enopace Biomedical Ltd.Detector-based arterial stimulation
US886224325 Jul 200614 Oct 2014Rainbow Medical Ltd.Electrical stimulation of blood vessels
US887421115 Dic 201028 Oct 2014Cardiac Pacemakers, Inc.Hypertension therapy based on activity and circadian rhythm
US887681314 Mar 20134 Nov 2014St. Jude Medical, Inc.Methods, systems, and apparatus for neural signal detection
US888018611 Abr 20134 Nov 2014Medtronic Ardian Luxembourg S.A.R.L.Renal neuromodulation for treatment of patients with chronic heart failure
US888019030 Nov 20124 Nov 2014Cvrx, Inc.Electrode structures and methods for their use in cardiovascular reflex control
US89093166 Jun 20119 Dic 2014St. Jude Medical, Cardiology Division, Inc.Apparatus and method of assessing transvascular denervation
US890933717 May 20129 Dic 2014Cardiac Pacemakers, Inc.System to treat AV-conducted ventricular tachyarrhythmia
US891574123 Ago 201123 Dic 2014Cardiac Pacemakers, Inc.Sleep quality data collection and evaluation
US892397225 Jul 200730 Dic 2014Vascular Dynamics, Inc.Elliptical element for blood pressure reduction
US892999015 Dic 20106 Ene 2015Cardiac Pacemakers, Inc.Transvascular neural stimulation device and method for treating hypertension
US89349751 Feb 201113 Ene 2015Metacure LimitedGastrointestinal electrical therapy
US893497822 Abr 201413 Ene 2015Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for renal neuromodulation
US893498816 Mar 201213 Ene 2015St. Jude Medical AbAblation stent with meander structure
US894886515 Nov 20133 Feb 2015Medtronic Ardian Luxembourg S.A.R.L.Methods for treating heart arrhythmia
US89562959 Sep 201317 Feb 2015Cardiac Pacemakers, Inc.Sleep detection using an adjustable threshold
US895887114 Ene 201117 Feb 2015Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US895887329 Abr 201017 Feb 2015Cardiac Pacemakers, Inc.Method and apparatus for safe and efficient delivery of cardiac stress augmentation pacing
US89744462 Feb 201110 Mar 2015St. Jude Medical, Inc.Ultrasound ablation apparatus with discrete staggered ablation zones
US897735928 Abr 201410 Mar 2015Cvrx, Inc.System for setting programmable parameters for an implantable hypertension treatment device
US897983915 Nov 201017 Mar 2015St. Jude Medical, Inc.Assembly of staggered ablation elements
US898359521 Nov 201317 Mar 2015Medtronic Ardian Luxembourg S.A.R.L.Renal neuromodulation for treatment of patients with chronic heart failure
US89862944 Feb 201024 Mar 2015Medtronic Ardian Luxembourg S.a.rl.Apparatuses for thermally-induced renal neuromodulation
US9002446 *30 Oct 20127 Abr 2015Pacesetter, Inc.Acquiring nerve activity from carotid body and/or sinus
US900510631 Ene 200814 Abr 2015Enopace Biomedical LtdIntra-aortic electrical counterpulsation
US901135530 Abr 201421 Abr 2015Sympara Medical, Inc.Methods and devices for treating hypertension
US901480930 Oct 201221 Abr 2015Pacesetter, Inc.Acquiring nerve activity from carotid body and/or sinus
US901481912 Nov 201321 Abr 2015Cardiac Pacemakers, Inc.Autonomic arousal detection system and method
US902059519 May 201028 Abr 2015Cardiac Pacemakers, Inc.Baroreflex activation therapy with conditional shut off
US902303723 Abr 20135 May 2015Medtronic Ardian Luxembourg S.A.R.L.Balloon catheter apparatus for renal neuromodulation
US902620630 Oct 20095 May 2015Medtronic, Inc.Therapy system including cardiac rhythm therapy and neurostimulation capabilities
US9026215 *29 Dic 20055 May 2015Cvrx, Inc.Hypertension treatment device and method for mitigating rapid changes in blood pressure
US90316507 Ene 201112 May 2015Cardiac Pacemakers, Inc.Closed loop neural stimulation synchronized to cardiac cycles
US903166912 Ago 201312 May 2015Cardiac Pacemakers, Inc.System for transvascularly stimulating autonomic targets
US904460918 Nov 20112 Jun 2015Cvrx, Inc.Electrode structures and methods for their use in cardiovascular reflex control
US907252715 Jul 20137 Jul 2015Medtronic Ardian Luxembourg S.A.R.L.Apparatuses and methods for renal neuromodulation
US907290123 Nov 20107 Jul 2015The Board Of Regents Of The University Of OklahomaCardiac neuromodulation and methods of using same
US90897007 Ago 200928 Jul 2015Cibiem, Inc.Systems and methods for treating dyspnea, including via electrical afferent signal blocking
US909571130 Jun 20144 Ago 2015Enteromedics Inc.Systems for regulation of blood pressure and heart rate
US910804026 Jun 201418 Ago 2015Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for multi-vessel renal neuromodulation
US911392928 Feb 201325 Ago 2015St. Jude Medical, Cardiology Division, Inc.Non-electric field renal denervation electrode
US912556729 Sep 20098 Sep 2015Vascular Dynamics, Inc.Devices and methods for control of blood pressure
US912566117 Oct 20138 Sep 2015Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for renal neuromodulation
US912573218 Feb 20118 Sep 2015Vascular Dynamics, Inc.Devices and methods for control of blood pressure
US913197823 Abr 201415 Sep 2015Medtronic Ardian Luxembourg S.A.R.L.Methods for bilateral renal neuromodulation
US913198214 Mar 201315 Sep 2015St. Jude Medical, Cardiology Division, Inc.Mediguide-enabled renal denervation system for ensuring wall contact and mapping lesion locations
US913828123 Sep 201322 Sep 2015Medtronic Ardian Luxembourg S.A.R.L.Methods for bilateral renal neuromodulation via catheter apparatuses having expandable baskets
US91496392 Abr 20136 Oct 2015Cardiac Pacemakers, Inc.Systems for using a pulmonary artery electrode
US917997315 Mar 201310 Nov 2015St. Jude Medical, Cardiology Division, Inc.Feedback systems and methods for renal denervation utilizing balloon catheter
US91799976 Mar 201310 Nov 2015St. Jude Medical, Cardiology Division, Inc.Thermochromic polyvinyl alcohol based hydrogel artery
US918619814 Sep 201217 Nov 2015Medtronic Ardian Luxembourg S.A.R.L.Ultrasound apparatuses for thermally-induced renal neuromodulation and associated systems and methods
US918621215 Mar 201317 Nov 2015St. Jude Medical, Cardiology Division, Inc.Feedback systems and methods utilizing two or more sites along denervation catheter
US918621315 May 201417 Nov 2015Medtronic Ardian Luxembourg S.A.R.L.Methods for renal neuromodulation
US919271521 Mar 201424 Nov 2015Medtronic Ardian Luxembourg S.A.R.L.Methods for renal nerve blocking
US919276931 Ago 200924 Nov 2015Medtronic, Inc.Shunt-current reduction techniques for an implantable therapy system
US921141213 Mar 201315 Dic 2015Cardiac Pacemakers, Inc.Closed loop neural stimulation synchronized to cardiac cycles
US922706829 Ago 20135 Ene 2016Cardiac Pacemakers, Inc.Concurrent therapy detection in implantable medical devices
US926555823 Abr 201423 Feb 2016Medtronic Ardian Luxembourg S.A.R.L.Methods for bilateral renal neuromodulation
US9265930 *16 Jul 201423 Feb 2016Metacure LimitedMethods and devices for modifying vascular parameters
US926594814 Oct 201423 Feb 2016Cardiac Pacemakers, Inc.Automatic neural stimulation modulation based on activity
US92830331 Jul 201315 Mar 2016Cibiem, Inc.Carotid body ablation via directed energy
US92892553 Mar 201522 Mar 2016Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for renal neuromodulation
US930804320 Nov 201412 Abr 2016Medtronic Ardian Luxembourg S.A.R.L.Methods for monopolar renal neuromodulation
US930804420 Nov 201412 Abr 2016Medtronic Ardian Luxembourg S.A.R.L.Methods for therapeutic renal neuromodulation
US931430029 Sep 201519 Abr 2016St. Jude Medical Cardiology Division, Inc.Feedback systems and methods for renal denervation utilizing balloon catheter
US931463020 Nov 201419 Abr 2016Medtronic Ardian Luxembourg S.A.R.L.Renal neuromodulation for treatment of patients
US931463510 Feb 200919 Abr 2016Cardiac Pacemakers, Inc.Automatic baroreflex modulation responsive to adverse event
US932056120 Nov 201426 Abr 2016Medtronic Ardian Luxembourg S.A.R.L.Methods for bilateral renal neuromodulation
US93268171 Dic 20143 May 2016Medtronic Ardian Luxembourg S.A.R.L.Methods for treating heart arrhythmia
US93271222 Feb 20153 May 2016Medtronic Ardian Luxembourg S.A.R.L.Methods for catheter-based renal neuromodulation
US936428017 Dic 201414 Jun 2016Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US938699131 Ene 201312 Jul 2016Rainbow Medical Ltd.Pressure-enhanced blood flow treatment
US939307024 Abr 201319 Jul 2016Cibiem, Inc.Endovascular catheters and methods for carotid body ablation
US93989303 Jun 201326 Jul 2016Cibiem, Inc.Percutaneous methods and devices for carotid body ablation
US94026773 Jun 20132 Ago 2016Cibiem, Inc.Methods and devices for cryogenic carotid body ablation
US94029922 Jul 20152 Ago 2016Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for multi-vessel renal neuromodulation
US94272838 Mar 201630 Ago 2016St. Jude Medical, Cardiology Division, Inc.Feedback systems and methods for renal denervation utilizing balloon catheter
US942757929 Sep 201130 Ago 2016Pacesetter, Inc.System and method for performing renal denervation verification
US942758330 Abr 201530 Ago 2016Cvrx, Inc.Electrode structures and methods for their use in cardiovascular reflex control
US943378428 Jul 20156 Sep 2016Cibiem, Inc.Systems and methods for treating dyspnea, including via electrical afferent signal blocking
US943972614 Mar 201613 Sep 2016Medtronic Ardian Luxembourg S.A.R.L.Methods for therapeutic renal neuromodulation
US94400781 Jul 201413 Sep 2016Cardiac Pacemakers, Inc.Neural stimulation modulation based on monitored cardiovascular parameter
US944586721 Mar 201620 Sep 2016Medtronic Ardian Luxembourg S.A.R.L.Methods for renal neuromodulation via catheters having expandable treatment members
US945686914 Mar 20164 Oct 2016Medtronic Ardian Luxembourg S.A.R.L.Methods for bilateral renal neuromodulation
US94571744 Dic 20144 Oct 2016Vascular Dynamics, Inc.Elliptical element for blood pressure reduction
US9457189 *5 May 20154 Oct 2016Cvrx, Inc.Hypertension treatment device and method for mitigating rapid changes in blood pressure
US94630668 Oct 201511 Oct 2016Medtronic Ardian Luxembourg S.A.R.L.Methods for renal neuromodulation
US946849714 Mar 201618 Oct 2016Medtronic Ardian Luxembourg S.A.R.L.Methods for monopolar renal neuromodulation
US947456316 Abr 201425 Oct 2016Medtronic Ardian Luxembourg S.A.R.L.Methods for renal neuromodulation
US94862703 Ago 20158 Nov 2016Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for bilateral renal neuromodulation
US95048368 Jul 201429 Nov 2016Cardiac Pacemakers, Inc.System and method to deliver therapy in presence of another therapy
US951090213 Mar 20136 Dic 2016St. Jude Medical, Cardiology Division, Inc.Ablation catheters and systems including rotational monitoring means
US95266379 Sep 201227 Dic 2016Enopace Biomedical Ltd.Wireless endovascular stent-based electrodes
US955004826 May 201124 Ene 2017Vascular Dynamics, Inc.Elliptical element for blood pressure reduction
US956107011 Mar 20147 Feb 2017St. Jude Medical, Cardiology Division, Inc.Ablation system, methods, and controllers
US956136920 Nov 20127 Feb 2017Medtronic, Inc.Techniques for placing medical leads for electrical stimulation of nerve tissue
US95613734 Feb 20167 Feb 2017Cardiac Pacemakers, Inc.System to stimulate a neural target and a heart
US957298230 Abr 200921 Feb 2017Medtronic, Inc.Techniques for placing medical leads for electrical stimulation of nerve tissue
US959213627 Nov 201314 Mar 2017Vascular Dynamics, Inc.Devices and methods for control of blood pressure
US959750530 Ene 200921 Mar 2017Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US961623130 Jul 201511 Abr 2017Enteromedics Inc.Systems for regulation of blood pressure and heart rate
US96361743 Mar 20162 May 2017Medtronic Ardian Luxembourg S.A.R.L.Methods for therapeutic renal neuromodulation
US964272624 Abr 20129 May 2017Vascular Dynamics, Inc.Devices and methods for control of blood pressure
US964948716 Ago 201316 May 2017Enopace Biomedical Ltd.Enhancing perfusion by contraction
US965607924 Sep 200923 May 2017Medtronic, Inc.Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions
US96754139 Feb 201613 Jun 2017Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for renal neuromodulation
US97070358 Ago 201618 Jul 2017Medtronic Ardian Luxembourg S.A.R.L.Methods for catheter-based renal neuromodulation
US971349011 Mar 201425 Jul 2017St. Jude Medical, Cardiology Division, Inc.Ablation system, methods, and controllers
US971349426 Jul 201625 Jul 2017St. Jude Medical, Cardiology Division, Inc.Feedback systems and methods for renal denervation utilizing balloon catheter
US972451416 Dic 20108 Ago 2017Medtronic, Inc.Variation of neural stimulation parameters
US97311321 Sep 201615 Ago 2017Medtronic Ardian Luxembourg S.A.R.L.Methods for renal neuromodulation
US974398314 Mar 201629 Ago 2017Medtronic Ardian Luxembourg S.A.R.L.Renal neuromodulation for treatment of patients
US975718019 Jul 201612 Sep 2017Cibiem, Inc.Endovascular catheters and methods for carotid body ablation
US975719217 Mar 201612 Sep 2017Medtronic Ardian Luxembourg S.A.R.L.Renal neuromodulation for treatment of patients
US975719328 Abr 201612 Sep 2017Medtronic Ardian Luxembourg S.A.R.L.Balloon catheter apparatus for renal neuromodulation
US20020107553 *26 Oct 20018 Ago 2002Medtronic, Inc.Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions
US20020143369 *26 Oct 20013 Oct 2002Medtronic, Inc.Method and apparatus to minimize effects of a cardiac insult
US20030004549 *26 Oct 20012 Ene 2003Medtronic, Inc.Method and apparatus to minimize the effects of a cardiac insult
US20030100924 *22 Abr 200229 May 2003Foreman Robert D.Cardiac neuromodulation and methods of using same
US20030149450 *3 Feb 20037 Ago 2003Mayberg Marc R.Brainstem and cerebellar modulation of cardiovascular response and disease
US20040019364 *27 Mar 200329 Ene 2004Cvrx, Inc.Devices and methods for cardiovascular reflex control via coupled electrodes
US20040254616 *5 Abr 200416 Dic 2004Cvrx, Inc.Stimulus regimens for cardiovascular reflex control
US20050096710 *21 Sep 20045 May 2005Cvrx, Inc.Baroreceptor activation for epilepsy control
US20050115561 *17 Sep 20042 Jun 2005Stahmann Jeffrey E.Patient monitoring, diagnosis, and/or therapy systems and methods
US20050143779 *13 Sep 200430 Jun 2005Cardiac Pacemakers, Inc.Baroreflex modulation based on monitored cardiovascular parameter
US20050143785 *8 Jun 200430 Jun 2005Imad LibbusBaroreflex therapy for disordered breathing
US20050149126 *24 Dic 20037 Jul 2005Imad LibbusBaroreflex stimulation to treat acute myocardial infarction
US20050149127 *24 Dic 20037 Jul 2005Imad LibbusAutomatic baroreflex modulation responsive to adverse event
US20050149130 *24 Dic 20037 Jul 2005Imad LibbusBaroreflex stimulation synchronized to circadian rhythm
US20050149131 *24 Dic 20037 Jul 2005Imad LibbusBaroreflex modulation to gradually decrease blood pressure
US20050149132 *24 Dic 20037 Jul 2005Imad LibbusAutomatic baroreflex modulation based on cardiac activity
US20050149143 *24 Dic 20037 Jul 2005Imad LibbusBaroreflex stimulator with integrated pressure sensor
US20050149155 *24 Dic 20037 Jul 2005Avram ScheinerStimulation lead for stimulating the baroreceptors in the pulmonary artery
US20050228459 *3 Jun 200513 Oct 2005Levin Howard RRenal nerve stimulation method and apparatus for treatment of patients
US20050228460 *3 Jun 200513 Oct 2005Levin Howard RRenal nerve stimulation method and apparatus for treatment of patients
US20050234523 *3 Jun 200520 Oct 2005Levin Howard RRenal nerve stimulation method and apparatus for treatment of patients
US20050251212 *20 Jul 200510 Nov 2005Cvrx, Inc.Stimulus regimens for cardiovascular reflex control
US20050288728 *8 Jun 200429 Dic 2005Imad LibbusAdaptive baroreflex stimulation therapy for disordered breathing
US20050288729 *8 Jun 200429 Dic 2005Imad LibbusCoordinated therapy for disordered breathing including baroreflex modulation
US20050288730 *13 May 200529 Dic 2005Mark DeemMethods and apparatus for renal neuromodulation
US20060004417 *27 Jun 20055 Ene 2006Cvrx, Inc.Baroreflex activation for arrhythmia treatment
US20060025821 *20 May 20052 Feb 2006Mark GelfandMethods and devices for renal nerve blocking
US20060041277 *25 Jul 200523 Feb 2006Mark DeemMethods and apparatus for renal neuromodulation
US20060079945 *12 Oct 200413 Abr 2006Cardiac Pacemakers, Inc.System and method for sustained baroreflex stimulation
US20060089678 *13 Mar 200327 Abr 2006Alon ShalevTechnique for blood pressure regulation
US20060111626 *29 Dic 200525 May 2006Cvrx, Inc.Electrode structures having anti-inflammatory properties and methods of use
US20060111745 *3 Nov 200525 May 2006Foreman Robert DCardiac neuromodulation and methods of using same
US20060111746 *23 Nov 200525 May 2006Foreman Robert DCardiac neuromodulation and methods of using same
US20060142801 *4 Nov 200529 Jun 2006Ardian, Inc.Methods and apparatus for intravascularly-induced neuromodulation
US20060206150 *6 Mar 200614 Sep 2006Ardian, Inc.Methods and apparatus for treating acute myocardial infarction
US20060212076 *6 Mar 200621 Sep 2006Ardian, Inc.Methods and apparatus for treating end-stage renal disease
US20060224188 *5 Abr 20055 Oct 2006Cardiac Pacemakers, Inc.Method and apparatus for synchronizing neural stimulation to cardiac cycles
US20060224202 *5 Abr 20055 Oct 2006Julia MoffittSystem to treat AV-conducted ventricular tachyarrhythmia
US20060235474 *12 Jun 200619 Oct 2006Ardian, Inc.Methods and apparatus for multi-vessel renal neuromodulation
US20060259084 *10 May 200516 Nov 2006Cardiac Pacemakers, Inc.System with left/right pulmonary artery electrodes
US20060259085 *10 May 200516 Nov 2006Cardiac Pacemakers, Inc.Neural stimulation system with pulmonary artery lead
US20060265014 *6 Mar 200623 Nov 2006Ardian, Inc.Methods and apparatus for bilateral renal neuromodulation
US20060265015 *13 Abr 200623 Nov 2006Ardian, Inc.Methods and apparatus for monopolar renal neuromodulation
US20060271111 *6 Mar 200630 Nov 2006Ardian, Inc.Methods and apparatus for treating contrast nephropathy
US20060276852 *6 Mar 20067 Dic 2006Ardian, Inc.Methods and apparatus for treating hypertension
US20070016115 *30 Jun 200618 Ene 2007Gerhard BuchholtzShockwave system controlled dependent on patient's blood pressure
US20070021792 *30 Jun 200625 Ene 2007Cvrx, Inc.Baroreflex Modulation Based On Monitored Cardiovascular Parameter
US20070021794 *30 Jun 200625 Ene 2007Cvrx, Inc.Baroreflex Therapy for Disordered Breathing
US20070021796 *7 Jul 200625 Ene 2007Cvrx, Inc.Baroreflex modulation to gradually decrease blood pressure
US20070021797 *7 Jul 200625 Ene 2007Cvrx, Inc.Baroreflex stimulation synchronized to circadian rhythm
US20070021799 *7 Jul 200625 Ene 2007Cvrx, Inc.Automatic baroreflex modulation based on cardiac activity
US20070027493 *20 Ene 20061 Feb 2007Shlomo Ben-HaimGastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US20070027497 *27 Jul 20051 Feb 2007Cyberonics, Inc.Nerve stimulation for treatment of syncope
US20070038259 *7 Jul 200615 Feb 2007Cvrx, Inc.Method and apparatus for stimulation of baroreceptors in pulmonary artery
US20070038260 *7 Jul 200615 Feb 2007Cvrx, Inc.Stimulation lead for stimulating the baroreceptors in the pulmonary artery
US20070038261 *7 Jul 200615 Feb 2007Cvrx, Inc.Lead for stimulating the baroreceptors in the pulmonary artery
US20070038262 *7 Jul 200615 Feb 2007Cvrx, Inc.Baroreflex stimulation system to reduce hypertension
US20070060972 *27 Sep 200615 Mar 2007Cvrx, Inc.Devices and methods for cardiovascular reflex treatments
US20070083239 *23 Sep 200512 Abr 2007Denise DemaraisMethods and apparatus for inducing, monitoring and controlling renal neuromodulation
US20070106340 *27 Sep 200610 May 2007Cvrx, Inc.Electrode structures and methods for their use in cardiovascular reflex control
US20070142864 *9 Nov 200621 Jun 2007Imad LibbusAutomatic neural stimulation modulation based on activity
US20070142879 *19 Dic 200621 Jun 2007The Cleveland Clinic FoundationApparatus and method for modulating the baroreflex system
US20070156198 *28 Dic 20065 Jul 2007Cvrx, Inc.Coordinated therapy for disordered breathing including baroreflex modulation
US20070156200 *29 Dic 20055 Jul 2007Lilian KornetSystem and method for regulating blood pressure and electrolyte balance
US20070156201 *29 Dic 20055 Jul 2007Cvrx, Inc.Hypertension treatment device and method for mitigating rapid changes in blood pressure
US20070161873 *13 Mar 200712 Jul 2007Cardiac Pacemakers, Inc.Sleep detection using an adjustable threshold
US20070161912 *10 Ene 200612 Jul 2007Yunlong ZhangAssessing autonomic activity using baroreflex analysis
US20070167984 *7 Jul 200619 Jul 2007Cvrx, Inc.Method and apparatus for stimulation of baroreceptors
US20070173899 *19 Mar 200726 Jul 2007Ardian, Inc.Renal nerve stimulation method for treatment of patients
US20070185540 *17 Abr 20079 Ago 2007Shlomo Ben-HaimSmooth Muscle Controller
US20070185543 *13 Abr 20079 Ago 2007Cvrx, Inc.System and method for sustained baroreflex stimulation
US20070191895 *21 Nov 200616 Ago 2007Foreman Robert DActivation of cardiac alpha receptors by spinal cord stimulation produces cardioprotection against ischemia, arrhythmias, and heart failure
US20070191904 *14 Feb 200616 Ago 2007Imad LibbusExpandable stimulation electrode with integrated pressure sensor and methods related thereto
US20070203549 *27 Feb 200630 Ago 2007Ardian, Inc.Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US20070213773 *15 May 200713 Sep 2007Hill Michael RClosed-Loop Neuromodulation for Prevention and Treatment of Cardiac Conditions
US20070255379 *2 Feb 20071 Nov 2007Williams Michael SIntravascular device for neuromodulation
US20070276442 *8 Ago 200729 Nov 2007Cvrx, Inc.Implantable electrode assembly having reverse electrode configuration
US20080009916 *18 May 200710 Ene 2008Cvrx, Inc.Applications of heart rate variability analysis in electrotherapy affecting autonomic nervous system response
US20080009917 *21 May 200710 Ene 2008Cvrx, Inc.Applications of heart rate variability analysis in electrotherapy affecting autonomic nervous system response
US20080015659 *25 Sep 200717 Ene 2008Yi ZhangNeurostimulation systems and methods for cardiac conditions
US20080021504 *24 Jul 200624 Ene 2008Mccabe AaronClosed loop neural stimulation synchronized to cardiac cycles
US20080033501 *25 Jul 20077 Feb 2008Yossi GrossElliptical element for blood pressure reduction
US20080046052 *28 Abr 200621 Feb 2008Medtronic, Inc.Method and apparatus providing asynchronous neural stimulation
US20080051767 *21 May 200728 Feb 2008Cvrx, Inc.Characterization and modulation of physiologic response using baroreflex activation in conjunction with drug therapy
US20080051849 *31 Oct 200728 Feb 2008Shlomo Ben-HaimSmooth muscle controller
US20080058889 *31 Oct 20076 Mar 2008Shlomo Ben-HaimSmooth muscle controller
US20080058891 *31 Oct 20076 Mar 2008Shlomo Ben-HaimSmooth muscle controller
US20080097540 *14 Dic 200724 Abr 2008Cvrx, Inc.Ecg input to implantable pulse generator using carotid sinus leads
US20080140167 *22 Feb 200812 Jun 2008Cvrx, Inc.Implantable electrode assembly having reverse electrode configuration
US20080167694 *31 Oct 200710 Jul 2008Cvrx, Inc.Automatic neural stimulation based on activity
US20080167699 *31 Oct 200710 Jul 2008Cvrx, Inc.Method and Apparatus for Providing Complex Tissue Stimulation Parameters
US20080171923 *31 Oct 200717 Jul 2008Cvrx, Inc.Assessing autonomic activity using baroreflex analysis
US20080172101 *31 Oct 200717 Jul 2008Cvrx, Inc.Non-linear electrode array
US20080177339 *31 Oct 200724 Jul 2008Cvrx, Inc.Electrode contact configurations for cuff leads
US20080177348 *31 Oct 200724 Jul 2008Cvrx, Inc.Electrode contact configurations for an implantable stimulator
US20080177349 *31 Oct 200724 Jul 2008Cvrx, Inc.Apparatus and method for modulating the baroreflex system
US20080177364 *31 Oct 200724 Jul 2008Cvrx, Inc.Self-locking electrode assembly usable with an implantable medical device
US20080177365 *31 Oct 200724 Jul 2008Cvrx, Inc.Method and apparatus for electronically switching electrode configuration
US20080177366 *31 Oct 200724 Jul 2008Cvrx, Inc.Cuff electrode arrangement for nerve stimulation and methods of treating disorders
US20080208286 *30 Abr 200828 Ago 2008Cvrx, Inc.Baroreflex activation for pain control, sedation and sleep
US20080213331 *8 Abr 20084 Sep 2008Ardian, Inc.Methods and devices for renal nerve blocking
US20080215107 *16 Abr 20084 Sep 2008Japan As Represented By President Of National Cardiovascular CenterCardiac pacing system, blood pressure regulating system, and cardiac disease treatment system by substituting native biological regulatory function
US20080215111 *31 Oct 20074 Sep 2008Cvrx, Inc.Devices and Methods for Cardiovascular Reflex Control
US20080215117 *25 Jul 20064 Sep 2008Yossi GrossElectrical Stimulation of Blood Vessels
US20080228238 *23 May 200818 Sep 2008Cardiac Pacemakers, Inc.Automatic baroreflex modulation based on cardiac activity
US20080289920 *21 May 200827 Nov 2008Hoerbiger-Origa Holding AgPneumatic cylinder with a self-adjusting end position damping arrangement, and method for self-adjusting end position damping
US20090048641 *23 Oct 200819 Feb 2009Cardiac Pacemakers, Inc.Baroreflex stimulation to treat acute myocardial infarction
US20090069738 *16 Jul 200812 Mar 2009Cvrx, Inc.Electrode Structures Having Anti-Inflammatory Properties And Methods Of Use
US20090088816 *18 Mar 20052 Abr 2009Tami HarelGastrointestinal Methods And Apparatus For Use In Treating Disorders And Controlling Blood Sugar
US20090132002 *7 May 200821 May 2009Cvrx, Inc.Baroreflex activation therapy with conditional shut off
US20090143838 *27 Ene 20094 Jun 2009Imad LibbusBaroreflex modulation to gradually decrease blood pressure
US20090198294 *10 Abr 20096 Ago 2009Rossing Martin ABaroreflex activation for arrhythmia treatment
US20090198308 *31 Ene 20086 Ago 2009Enopace Biomedical Ltd.Intra-aortic electrical counterpulsation
US20090221939 *14 Ago 20063 Sep 2009Ardian, Inc.Methods and apparatus for thermally-induced renal neuromodulation
US20090228060 *20 May 200910 Sep 2009Imad LibbusMethod and apparatus for synchronizing neural stimulation to cardiac cycles
US20090234408 *28 May 200917 Sep 2009Julia MoffittSystem to treat av-conducted ventricular tachyarrhythmia
US20090234416 *10 Mar 200917 Sep 2009Zielinski John RIntermittent pacing therapy delivery statistics
US20090234418 *9 Abr 200917 Sep 2009Kieval Robert SDevices and methods for cardiovascular reflex control via coupled electrodes
US20090275956 *30 Abr 20095 Nov 2009Medtronic, Inc.Techniques for placing medical leads for electrical stimulation of nerve tissue
US20090275996 *30 Abr 20095 Nov 2009Medtronic, Inc.Techniques for placing medical leads for electrical stimulation of nerve tissue
US20090276022 *30 Abr 20095 Nov 2009Medtronic , Inc.Techniques for placing medical leads for electrical stimulation of nerve tissue
US20090276025 *30 Abr 20095 Nov 2009Medtronic, Inc.Techniques for placing medical leads for electrical stimulation of nerve tissue
US20100023088 *27 Mar 200928 Ene 2010Stack Richard SSystem and method for transvascularly stimulating contents of the carotid sheath
US20100077515 *5 Sep 200625 Mar 2010Northwestern UniversityMicrochannel forming method and nanotipped dispensing device having a microchannel
US20100114197 *30 Ene 20096 May 2010Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US20100114198 *30 Ene 20096 May 2010Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US20100114199 *30 Ene 20096 May 2010Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US20100114200 *30 Ene 20096 May 2010Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US20100114201 *30 Ene 20096 May 2010Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US20100114203 *30 Ene 20096 May 2010Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US20100114205 *30 Oct 20096 May 2010Medtronic, Inc.Shunt-current reduction housing for an implantable therapy system
US20100114208 *30 Ene 20096 May 2010Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US20100114211 *31 Ago 20096 May 2010Medtronic, Inc.Shunt-current reduction techniques for an implantable therapy system
US20100114217 *30 Oct 20096 May 2010Medtronic, Inc.Therapy system including cardiac rhythm therapy and neurostimulation capabilities
US20100114221 *30 Oct 20096 May 2010Medtronic, Inc.Therapy system including cardiac rhythm therapy and neurostimulation capabilities
US20100114224 *30 Ene 20096 May 2010Medtronic, Inc.Implantable medical device crosstalk evaluation and mitigation
US20100121399 *15 Ene 201013 May 2010Mccabe AaronClosed loop neural stimulation synchronized to cardiac cycles
US20100125307 *26 Ene 201020 May 2010Pastore Joseph MMulti-site ventricular pacing therapy with parasympathetic stimulation
US20100138340 *1 Feb 20103 Jun 2010John Earl ShireySystem and apparatus for transaction fraud processing
US20100174347 *10 Nov 20098 Jul 2010Kieval Robert SDevices and methods for cardiovascular reflex control via coupled electrodes
US20100179614 *8 Mar 201015 Jul 2010Kieval Robert SDevices and methods for cardiovascular reflex control
US20100185255 *30 Mar 201022 Jul 2010Imad LibbusBaroreflex stimulation synchronized to circadian rhythm
US20100191303 *24 Mar 201029 Jul 2010Cvrx, Inc.Automatic baroreflex modulation responsive to adverse event
US20100204741 *6 Ago 200912 Ago 2010Tweden Katherine SSystems for regulation of blood pressure and heart rate
US20100222832 *13 May 20102 Sep 2010Yongxing ZhangMethods for using a pulmonary artery electrode
US20100249874 *21 May 201030 Sep 2010Bolea Stephen LBaroreflex therapy for disordered breathing
US20100274321 *19 May 201028 Oct 2010Imad LibbusBaroreflex activation therapy with conditional shut off
US20100305648 *29 Abr 20102 Dic 2010Shantha Arcot-KrishnamurthyMethod and apparatus for safe and efficient delivery of cardiac stress augmentation pacing
US20100324620 *26 Ago 201023 Dic 2010Imad LibbusPercutaneous neurostimulator for modulating cardiovascular function
US20100324621 *26 Ago 201023 Dic 2010Imad LibbusTranscutaneous neurostimulator for modulating cardiovascular function
US20110009692 *28 Dic 200813 Ene 2011Yossi GrossNitric oxide generation to treat female sexual dysfunction
US20110066200 *23 Nov 201017 Mar 2011Foreman Robert DCardiac neuromodulation and methods of using same
US20110071584 *8 Sep 201024 Mar 2011Mokelke Eric AMethod and apparatus for automated control of pacing post-conditioning
US20110077729 *5 May 201031 Mar 2011Vascular Dynamics Inc.Devices and methods for control of blood pressure
US20110082514 *15 Dic 20107 Abr 2011Imad LibbusHypertension therapy based on activity and circadian rhythm
US20110082537 *15 Dic 20107 Abr 2011Julia MoffittTransvascular neural stimulation device
US20110106199 *7 Ene 20115 May 2011Mccabe AaronClosed loop neural stimulation synchronized to cardiac cycles
US20110106216 *10 Ene 20115 May 2011Imad LibbusBaroreflex stimulator with integrated pressure sensor
US20110118773 *2 Dic 201019 May 2011Rainbow Medical Ltd.Elliptical device for treating afterload
US20110137197 *15 Feb 20119 Jun 2011Stahmann Jeffrey EImplantable Device Employing Movement Sensing for Detecting Sleep-Related Disorders
US20110137370 *1 Dic 20109 Jun 2011Enopace Biomedical Ltd.Thoracic aorta and vagus nerve stimulation
US20110137374 *5 Nov 20109 Jun 2011Kieval Robert SDevices and methods for electrode implantation
US20110143648 *20 Dic 201016 Jun 2011Oy Halton Group Ltd.Automatic displacement ventilation system with heating mode
US20110144710 *18 Feb 201116 Jun 2011National Cerebral And Cardiovascular CenterCardiac pacing system by substituting native biological regulatory function
US20110144714 *23 Feb 201116 Jun 2011National Cerebral And Cardiovascular CenterBlood pressure regulating system by substituting native biological regulatory function
US20110166482 *7 Mar 20117 Jul 2011Stack Richard SSystem and method for transvascularly stimulating contents of the carotid sheath
US20110178416 *18 Feb 201121 Jul 2011Vascular Dynamics Inc.Devices and methods for control of blood pressure
US20110178570 *13 Dic 201021 Jul 2011Ardian, Inc.Methods and apparatus for multi-vessel renal neuromodulation
US20110202107 *15 Oct 200818 Ago 2011Kyushu University, National University CorporationBlood pressure stabilization system using transdermal stimulation
US20110207758 *24 Feb 201125 Ago 2011Medtronic Vascular, Inc.Methods for Therapeutic Renal Denervation
US20110208096 *11 Mar 201125 Ago 2011Ardian, Inc.Methods and apparatus for thermally-induced renal neuromodulation
US20110213408 *29 Sep 20091 Sep 2011Vascular Dynamics Inc.Devices and methods for control of blood pressure
US20140330333 *16 Jul 20146 Nov 2014Metacure LimitedMethods and devices for modifying vascular parameters
US20150251009 *5 May 201510 Sep 2015Cvrx, Inc.Hypertension treatment device and method for mitigating rapid changes in blood pressure
USD74749123 Oct 201312 Ene 2016St. Jude Medical, Cardiology Division, Inc.Ablation generator
USD77404323 Oct 201313 Dic 2016St. Jude Medical, Cardiology Division, Inc.Display screen with graphical user interface for ablation generator
USD79355924 Nov 20151 Ago 2017St. Jude Medical, Cardiology Division, Inc.Ablation generator
CN102458570A *13 May 201016 May 2012三森神经科学有限公司Endovascular electrostimulation near a carotid bifurcation in treating cerebrovascular conditions
CN102458570B13 May 20106 Ago 2014三森神经科学有限公司Endovascular electrostimulation near a carotid bifurcation in treating cerebrovascular conditions
EP2085114A3 *27 Sep 200128 Oct 2009CVRX, Inc.Devices and methods for cardiovascular reflex control
EP2233172A1 *15 Oct 200829 Sep 2010Kyushu University, National University CorporationBlood pressure stabilization system using transdermal stimulation
EP2233172A4 *15 Oct 200829 Jun 2011Univ Kyushu Nat Univ CorpBlood pressure stabilization system using transdermal stimulation
EP2399644A3 *27 Sep 200114 Mar 2012CVRX, Inc.Devices for cardiovascular reflex control
EP2446924A1 *15 Jun 20072 May 2012Cardiac Pacemakers, Inc.Transcutaneous neurostimulator for modulating cardiovascular function
WO1985001213A1 *11 Sep 198428 Mar 1985Jacob ZabaraNeurocybernetic prosthesis
WO1995017921A1 *27 Dic 19946 Jul 1995Horst Edgar KrauseMethod of electrical nerve stimulation
WO1999055413A1 *9 Abr 19994 Nov 1999Medtronic, Inc.Apparatus for treating peripheral vascular disease and organ ischemia
WO2002026314A1 *27 Sep 20014 Abr 2002Cvrx, Inc.Devices and methods for cardiovascular reflex control
WO2002028478A1 *3 Oct 200111 Abr 2002St. Jude Medical AbImplantable medical device with pressure measurement means
WO2002034327A226 Oct 20012 May 2002Medtronic, Inc.Method and apparatus to minimize the effects of a cardiac insult
WO2002034330A226 Oct 20012 May 2002Medtronic, Inc.Method and apparatus to minimize the effects of a cardiac insult
WO2002096512A126 Oct 20015 Dic 2002Medtronic, Inc.Closed-loop neuromodulation for prevention and treatment of cardiac conditions
WO2003076008A1 *13 Mar 200318 Sep 2003Brainsgate Ltd.Technique for blood pressure regulation
WO2006044025A1 *19 Ago 200527 Abr 2006Cardiac Pacemakers, Inc.System for sustained baroreflex stimulation
WO2006107675A129 Mar 200612 Oct 2006Cardiac Pacemakers, Inc.Cardiac cycle - synchronized neural stimulator
WO2007076281A113 Dic 20065 Jul 2007Medtronic, Inc.System and method for regulating blood pressure and electrolyte balance
WO2010131219A113 May 201018 Nov 2010Samson Neurosciences Ltd.Endovascular electrostimulation near a carotid bifurcation in treating cerebrovascular conditions
WO2013018083A2 *2 Ago 20127 Feb 2013Samson Neurosciences LtdElectrostimulation in treating cerebrovascular conditions
WO2013018083A3 *2 Ago 201221 Ago 2014Samson Neurosciences LtdElectrostimulation in treating cerebrovascular conditions
Clasificaciones
Clasificación de EE.UU.607/44, 607/72, 607/62
Clasificación internacionalA61N1/365, A61N1/32, A61B5/0215, A61N1/36, A61N1/372
Clasificación cooperativaA61N1/36564, A61N1/36117, A61B5/0215, A61B5/7239
Clasificación europeaA61B5/0215, A61N1/365B9